| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Nov 22, 2024 | Nov 25, 2024 | Lineage Cell Therapeutics, Inc. | Director | Buy | 91.3 | +40,000 | 15.47% | ✗ | $22.6K |
| Mar 24, 2022 | Mar 25, 2022 | Lineage Cell Therapeutics, Inc. | Director | Buy | 82.5 | +7,000 | 2.78% | ✗ | $9.8K |